 Predictive Oncology Inc. NASDAQ:POAI announced it has appointed Julia Kirshner to the newly-created role of Chief Scientific Officer CSO. Kirshner, who up until now served as senior vice president at Predictive Oncology and president of its zPREDICTA division, will assume the role on August 1. 